文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

叶黄素通过促进线粒体功能和抑制游离脂肪酸诱导的 HepG2 细胞中的 p53 通路来预防铁死亡。

Zeaxanthin prevents ferroptosis by promoting mitochondrial function and inhibiting the p53 pathway in free fatty acid-induced HepG2 cells.

机构信息

College of Life Science, Jilin Agricultural University, Changchun, Jilin 130118, China; College of Food Science and Engineering, Jilin Agricultural University, Changchun, Jilin 130118, China; National Engineering Research Center for Wheat and Corn Deep Processing, Changchun, Jilin 130118, China.

College of Life Science, Jilin Agricultural University, Changchun, Jilin 130118, China.

出版信息

Biochim Biophys Acta Mol Cell Biol Lipids. 2023 Apr;1868(4):159287. doi: 10.1016/j.bbalip.2023.159287. Epub 2023 Jan 21.


DOI:10.1016/j.bbalip.2023.159287
PMID:36690321
Abstract

Non-alcoholic fatty liver disease (NAFLD) is a common liver disorder worldwide and a risk factor for obesity and diabetes. Emerging evidence has shown that ferroptosis is involved in the progression of NAFLD. Zeaxanthin (ZEA) is a carotenoid found in human serum. It has been reported that ZEA can ameliorate obesity, prevent age-related macular degeneration, and protect against non-alcoholic steatohepatitis. However, no study has focused on the protective effects of ZEA against NAFLD. In this study, free fatty acid (FFA) induced HepG2 cells were used as a cell model for NAFLD. Our results suggest that ZEA exerts antioxidative and anti-inflammatory effects in FFA-induced HepG2 cells. Moreover, ZEA acted as a ferroptosis inhibitor, significantly reducing reactive oxygen species (ROS) generation and iron overload and improving mitochondrial dysfunction in FFA-induced HepG2 cells. In addition, ZEA downregulated the expression of p53 and modulated downstream targets, such as GPX4, SLC7A11, SAT1, and ALOX15, which contributed to the reduction in cellular lipid peroxidation. Our findings suggest that ZEA has the potential for NAFLD intervention.

摘要

非酒精性脂肪性肝病(NAFLD)是一种全球范围内常见的肝脏疾病,也是肥胖症和糖尿病的一个风险因素。新出现的证据表明,铁死亡与 NAFLD 的进展有关。玉米黄质(ZEA)是一种存在于人体血清中的类胡萝卜素。据报道,ZEA 可以改善肥胖症,预防年龄相关性黄斑变性,并防止非酒精性脂肪性肝炎。然而,尚无研究关注 ZEA 对 NAFLD 的保护作用。在这项研究中,使用游离脂肪酸(FFA)诱导的 HepG2 细胞作为 NAFLD 的细胞模型。我们的结果表明,ZEA 在 FFA 诱导的 HepG2 细胞中发挥抗氧化和抗炎作用。此外,ZEA 作为铁死亡抑制剂,可显著减少活性氧(ROS)的产生和铁过载,并改善 FFA 诱导的 HepG2 细胞中线粒体功能障碍。此外,ZEA 下调了 p53 的表达,并调节下游靶点,如 GPX4、SLC7A11、SAT1 和 ALOX15,这有助于减少细胞脂质过氧化。我们的研究结果表明,ZEA 具有干预 NAFLD 的潜力。

相似文献

[1]
Zeaxanthin prevents ferroptosis by promoting mitochondrial function and inhibiting the p53 pathway in free fatty acid-induced HepG2 cells.

Biochim Biophys Acta Mol Cell Biol Lipids. 2023-4

[2]
Spermidine mitigates ferroptosis in free fatty acid-induced AML-12 cells through the ATF4/SLC7A11/GCLM/GPX4 pathway.

Biochim Biophys Acta Mol Cell Biol Lipids. 2024-12

[3]
Exploratory Data Analysis of Cell and Mitochondrial High-Fat, High-Sugar Toxicity on Human HepG2 Cells.

Nutrients. 2021-5-19

[4]
Melatonin targets ferroptosis through bimodal alteration of redox environment and cellular pathways in NAFLD model.

Biosci Rep. 2023-10-31

[5]
Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease.

Metabolism. 2024-8

[6]
Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease.

Toxicology. 2020-12-1

[7]
Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model.

J Med Food. 2016-5

[8]
Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.

Phytomedicine. 2018-7-18

[9]
Gentiopicroside Ameliorates Oxidative Stress and Lipid Accumulation through Nuclear Factor Erythroid 2-Related Factor 2 Activation.

Oxid Med Cell Longev. 2020

[10]
SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway.

Int J Mol Sci. 2020-6-25

引用本文的文献

[1]
Melatonin Prevents the Progression of MASLD via Inhibiting FFAs-Induced Ferroptosis through KEAP1/NRF2/HO-1 Pathway.

Biomol Ther (Seoul). 2025-9-1

[2]
Killing hepatocellular carcinoma in the NAFLD/NASH stage: a comprehensive perspective on targeting regulated cell death.

Cell Death Discov. 2025-6-19

[3]
Alterations in Glutathione Redox Homeostasis in Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review.

Antioxidants (Basel). 2024-11-28

[4]
Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects.

Signal Transduct Target Ther. 2024-10-14

[5]
The role of SLC7A11 in diabetic wound healing: novel insights and new therapeutic strategies.

Front Immunol. 2024

[6]
The role of ferroptosis in acute kidney injury: mechanisms and potential therapeutic targets.

Mol Cell Biochem. 2025-2

[7]
Recent Advances in the Therapeutic Potential of Carotenoids in Preventing and Managing Metabolic Disorders.

Plants (Basel). 2024-6-7

[8]
Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective.

Metabolites. 2024-4-12

[9]
Updated mechanisms of MASLD pathogenesis.

Lipids Health Dis. 2024-4-22

[10]
Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications.

Antioxidants (Basel). 2024-3-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索